# Progress Note 04 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Martin Luther King Jr. (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML001-SYN-TD
- Date: 1965-06-02
- Fictional facility: St. Posthumous Health Center
- Fictional author: Cornelius Ashby-Nwankwo, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Eight-week review of depression, sleep, smoking and home blood pressure. **S**

## History of present illness

Dr. King returns three weeks after his preventive visit. The nurse telephone call planned two weeks after starting sertraline did not reach him because he was travelling; he took sertraline 50 mg daily, with nausea for a few days only. He has had six therapy sessions and keeps a fixed rising time; he now sleeps about six hours. He stopped smoking on his quit date two weeks ago, using varenicline, and has mild nausea after the morning dose and vivid dreams, but no change in mood; cravings come late at night when he writes. He has kept his day off on four of the past six weeks. His home blood pressure readings over seven days averaged 136/86. He has had no thoughts of harming himself. **S**

| Element | Detail |
|---|---|
| Sertraline | 50 mg for five weeks; early nausea only |
| Missed call | Two-week nurse call did not reach him |
| Smoking | Stopped two weeks ago on varenicline; night cravings |
| Home blood pressure | Seven-day average 136/86 |
| Sleep | About six hours |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Less tired |
| Respiratory | Negative | Morning cough easing since he stopped smoking |
| Gastrointestinal | Positive | Mild nausea after the morning varenicline dose |
| Neurological | Negative | No headaches |
| Psychiatric | Positive | Mood better; vivid dreams; PHQ-9 11; no suicidal ideation |

5 systems reviewed. **S**

## Current medications

- Varenicline 1 mg tablet, one by mouth twice daily after food **S**
- Sertraline 50 mg tablet, one by mouth each morning **S**

## Allergies

- No known allergy **S**

## Objective

BP 134/86 mmHg; pulse 76 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 84.6 kg; BMI 29.3 kg/m². All vital signs are synthetic.

PHQ-9: 11; GAD-7: 7; Urine albumin-to-creatinine ratio: 8 mg/g. All results are synthetic.

## Change since baseline

- PHQ-9: 17 at baseline, 11 at this visit **S**
- GAD-7: 11 at baseline, 7 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Blood pressure 134/86, pulse 76; weight 84.6 kg, BMI 29.3 |
| Eyes | Fundi: no hypertensive retinopathy |
| Cardiovascular | Regular rhythm; no murmur or added sounds |
| Psychiatric | Brighter; reactive affect; no suicidal ideation |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Stage 1 hypertension** (I10). The raised clinic readings are confirmed at home: a seven-day average of 136/86 is stage 1 hypertension by the 1956 ACC/AHA guideline. No end-organ damage: ECG normal at intake, urine albumin-to-creatinine ratio 8 mg/g, eGFR 95 and normal fundi. At 36, without diabetes, kidney disease or vascular disease, his estimated 10-year risk is low, so lifestyle treatment comes first. The PREVENT equations were used for the estimate; the Pooled Cohort Equations do not apply under 40. Stopping smoking, which he has just done, is the most important change for his heart. **S**
   - Sodium below 2,300 mg a day, aiming for 1,500 mg; DASH-style meals, including on the road.
   - Brisk walking for 30 minutes on five days a week.
   - Aim for 5 percent weight loss.
   - Home readings for a week before each visit.
   - Medicine if home readings stay at or above 130/80 after three to six months.
2. **Major depressive disorder, improving** (F32.1). PHQ-9 11, from 17: improving but not yet a 50 percent response after five weeks of sertraline 50 mg and six sessions. GAD-7 7. No change in mood on varenicline. **S**
   - Continue sertraline 50 mg; consider 100 mg if the PHQ-9 is not clearly lower at the next visit.
   - Continue weekly therapy.
   - Safety plan reviewed and unchanged; 988 Suicide & Crisis Lifeline and the clinic number confirmed.
3. **Nicotine dependence, quit two weeks ago** (F17.210). Smoke-free for two weeks on varenicline 1 mg twice daily; mild nausea and vivid dreams are common and tolerable. **S**
   - Take varenicline with food and a full glass of water.
   - Continue weekly quitline calls; a plan for late-night writing with sugar-free gum and a walk.
4. **Insomnia disorder, improving** (G47.00). Insomnia Severity Index 13, from 18; about six hours a night. **S**
   - Widen the sleep window by 15 minutes.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | PHQ-9 | At least monthly during acute treatment; every 2 to 4 weeks in continuation | Completed today | 11, from 17 at intake |
| Survey | GAD-7 | Every 4 to 8 weeks during treatment | Completed today | 7, from 11 |
| Survey | Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9) | Every visit | Completed today | No suicidal ideation; PHQ-9 item 9 scored 0; no mood change on varenicline. Safety plan reviewed |
| Medication safety | SSRI tolerability check two weeks after starting | 2 weeks after starting and after each dose change | Deferred | Protocol deviation: the nurse telephone call due two weeks after sertraline started did not reach him because he was travelling, and no second attempt was made. His tolerability and mood were checked at the preventive visit three weeks after starting, when he reported only brief nausea and no suicidal thoughts, so no harm resulted. Corrective action: calls are now booked through his office's travel schedule, with a second attempt within two days |
| Medication safety | Varenicline neuropsychiatric and adverse-effect review | Weekly by quitline for the first weeks, and every visit | Completed today | Mild nausea and vivid dreams; no agitation, low mood or unusual thoughts |
| Self-management | Smoking status after the quit date | Every visit | Completed today | Smoke-free for two weeks by his report |
| Survey | Insomnia Severity Index and sleep diary | Every visit during CBT for insomnia | Completed today | Insomnia Severity Index 13; about six hours a night (score in the notes; no LOINC code used) |
| Examination | Out-of-office blood pressure to confirm the diagnosis | Before diagnosis and when treatment changes | Completed today | Seven-day home average 136/86 on a validated arm monitor |
| Examination | Office blood pressure, weight and BMI | Every visit | Completed today | 134/86 mmHg; weight 84.6 kg, BMI 29.3 |
| Laboratory | Urine albumin-to-creatinine ratio | At diagnosis, then yearly | Completed today | 8 mg/g, normal |
| Laboratory | Basic metabolic panel, TSH, glucose or A1c, and lipids at diagnosis | At diagnosis, then yearly | Up to date | Drawn at intake eight weeks ago: all normal except LDL 142 mg/dL |
| Imaging | 12-lead ECG at diagnosis | Baseline | Up to date | Normal at intake |
| Examination | Fundoscopic examination | At diagnosis, then yearly | Completed today | No hypertensive retinopathy |
| Survey | 10-year cardiovascular risk | Yearly | Completed today | Low by the PREVENT equations; the Pooled Cohort Equations do not apply under 40 |
| Self-management | Sustainable work plan: a day off each week, two speeches a day at most, sleep window kept | Every visit | Completed today | Day off kept on four of six weeks; two speeches a day at most on most days |

## Goal progress

- Depression remission (PHQ-9 below 5) by six months. In progress; target 1965-09-15. **S**
- Sleep of at least six and a half hours on most nights, with an Insomnia Severity Index below 10. In progress; target 1965-09-15. **S**
- Smoke-free, confirmed at every visit after the quit date. In progress; target 1965-11-30. **S**
- Home blood pressure below 130/80 mmHg with lifestyle changes. In progress; target 1965-12-31. **S**
- A sustainable schedule: one full day a week without work, no more than two speeches a day, and a two-week break in the summer. In progress; target 1965-07-14. **S**

## Guideline basis

- Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019), American Psychological Association
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders, hypertension and hyperlipidemia monographs (2026), Aether Forge
- VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022), United States Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016), American College of Physicians (Qaseem A, et al. Ann Intern Med 2016;165(2):125-133)
- Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021), U.S. Preventive Services Task Force
- Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES) (2016), The Lancet (Anthenelli RM, et al. Lancet 2016;387(10037):2507-2520)
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2017), American College of Cardiology and American Heart Association (Whelton PK, et al. Hypertension 2018;71(6):e13-e115)
- Development and Validation of the American Heart Association's PREVENT Equations (2024), Circulation (Khan SS, et al. Circulation 2024;149(6):430-449)

## Follow-up

- Home blood pressure for a week before the next visit. Review in six weeks. **S**
- Next scheduled visit 1965-07-14: fourteen-week review: mood, sleep, varenicline, blood pressure and the work plan. **S**
